Cargando…

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis

Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more se...

Descripción completa

Detalles Bibliográficos
Autores principales: Spielman, Daniel B., Overdevest, Jonathan, Gudis, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729240/
https://www.ncbi.nlm.nih.gov/pubmed/33336175
http://dx.doi.org/10.1016/j.wjorl.2020.07.001
_version_ 1783621413748342784
author Spielman, Daniel B.
Overdevest, Jonathan
Gudis, David A.
author_facet Spielman, Daniel B.
Overdevest, Jonathan
Gudis, David A.
author_sort Spielman, Daniel B.
collection PubMed
description Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.
format Online
Article
Text
id pubmed-7729240
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-77292402020-12-16 Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis Spielman, Daniel B. Overdevest, Jonathan Gudis, David A. World J Otorhinolaryngol Head Neck Surg Review Article Patients with aspirin exacerbated respiratory disease (AERD) experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma, which are exacerbated by aspirin/NSAID ingestion. As compared with aspirin-tolerant CRSwNP, patients with AERD experience more severe olfactory dysfunction, which is one of the key contributors to the observed decrease in quality of life (QOL) in this disease. The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities. KeAi Publishing 2020-08-26 /pmc/articles/PMC7729240/ /pubmed/33336175 http://dx.doi.org/10.1016/j.wjorl.2020.07.001 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Spielman, Daniel B.
Overdevest, Jonathan
Gudis, David A.
Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_full Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_fullStr Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_full_unstemmed Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_short Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
title_sort olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729240/
https://www.ncbi.nlm.nih.gov/pubmed/33336175
http://dx.doi.org/10.1016/j.wjorl.2020.07.001
work_keys_str_mv AT spielmandanielb olfactoryoutcomesinthemanagementofaspirinexacerbatedrespiratorydiseaserelatedchronicrhinosinusitis
AT overdevestjonathan olfactoryoutcomesinthemanagementofaspirinexacerbatedrespiratorydiseaserelatedchronicrhinosinusitis
AT gudisdavida olfactoryoutcomesinthemanagementofaspirinexacerbatedrespiratorydiseaserelatedchronicrhinosinusitis